4//SEC Filing
Garfield Greg Shaw 4
Accession 0001209191-21-028189
CIK 0001528287other
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 7:27 PM ET
Size
7.0 KB
Accession
0001209191-21-028189
Insider Transaction Report
Form 4
NeuroPace IncNPCE
Garfield Greg Shaw
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-04-21+21,698→ 21,698 totalExercise: $17.00Exp: 2031-04-20→ Common Stock (21,698 underlying) - Purchase
Common Stock
2021-04-21$17.00/sh+13,235$224,995→ 38,853 total
Footnotes (2)
- [F1]Reflects shares purchased from the underwriters in the Companys initial public offering.
- [F2]1/36th of the shares subject to the option vest in equal monthly installments commencing May 21, 2021.
Documents
Issuer
NeuroPace Inc
CIK 0001528287
Entity typeother
Related Parties
1- filerCIK 0001594406
Filing Metadata
- Form type
- 4
- Filed
- Apr 22, 8:00 PM ET
- Accepted
- Apr 23, 7:27 PM ET
- Size
- 7.0 KB